S
Suzanne Oparil
Researcher at University of Alabama at Birmingham
Publications - 941
Citations - 122414
Suzanne Oparil is an academic researcher from University of Alabama at Birmingham. The author has contributed to research in topics: Blood pressure & Angiotensin II. The author has an hindex of 106, co-authored 885 publications receiving 113983 citations. Previous affiliations of Suzanne Oparil include Michigan State University & Oregon Health & Science University.
Papers
More filters
Journal ArticleDOI
Regional myocyte size in normotensive and spontaneously hypertensive rats.
TL;DR: Left ventricular cells of SHR were larger than left ventricular Cells of WKY or Fischer rats in proportion to the increase in total heart weight, indicating that cardiac enlargement in SHR is due to increased cell size rather than increased cell number.
Journal ArticleDOI
Management of hypertension in the elderly
Eduardo Pimenta,Suzanne Oparil +1 more
TL;DR: No clear evidence exists to support recommendations for the use of particular antihypertensive-drug classes in older adults, and all guidelines recommend lifestyle modifications and medical treatment for elderly patients whose blood pressure exceeds prescribed thresholds and who are at moderate or high cardiovascular disease risk.
Journal ArticleDOI
Estrogen inhibits vascular smooth muscle cell-dependent adventitial fibroblast migration in vitro
TL;DR: A novel mechanism of hormonal vasoprotection by which estrogen directly modulates VSMC expression of factor(s) controlling migration of adventitial fibroblasts via an ER-dependent mechanism is suggested.
Journal ArticleDOI
Association of Blood Pressure Classification Using the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline with Risk of Heart Failure and Atrial Fibrillation
Hidehiro Kaneko,Yuichiro Yano,Yuichiro Yano,Hidetaka Itoh,Kojiro Morita,Kojiro Morita,Hiroyuki Kiriyama,Tatsuya Kamon,Katsuhito Fujiu,Nobuaki Michihata,Taisuke Jo,Norifumi Takeda,Hiroyuki Morita,Koichi Node,Robert M. Carey,Joao A.C. Lima,Suzanne Oparil,Hideo Yasunaga,Issei Komuro +18 more
TL;DR: In this paper, the authors assessed the extent stage 1 hypertension in the 2017 American College of Cardio-Anatomical Diseases (ACCAD) survey, and found that the prevalence of heart failure (HF) and atrial fibrillation (AF) is growing in prevalence worldwide.
Journal ArticleDOI
Sleep apnea, aldosterone, and resistant hypertension.
TL;DR: Patients diagnosed with this triad should be treated with low-salt diet, weight-loss counseling, and continuous positive airway pressure, as well as aggressive antihypertensive therapy, usually with multiple agents, including a mineralocorticoid receptor antagonist.